 |
|
 |
1. Platelet-derived endothelial cell growth factor/thymidine phosphorylase, 2-deoxy-D-ribose and angiogenesis
2. Vascular targeting of anti-cancer gene therapy
Roy Bicknell
Oxford Univ. UK
|
|
 |
Essential functions of a chemokine SDF-I/PBSF in organ vascularization
Takashi Nagasawa
Stanford Univ., USA
|
|
|
|
|
 |
Nitric oxide, vascular remodeling and angiogenesis
John P. Cooke
Stanford Univ. USA
|
|
 |
Its pathophysiological implication and molecular regulation
Katsuo Sueishi
Kyushyu Univ. Japan
|
|
|
|
|
|
Emerging lessons from clinical trials of angiogenesis based therapies
William W. Li
The Angiogenesis Foundation, USA
|
|
|
Genetic innovation for bypass grafts and neovascularization
Michael J. Mann
University of Claifornia, San Francisco
|
|
|
|
|
 |
A common hypoxia-inducible angiogenic factor in tumorigenesis and embryogenesis
Kyu-Won Kim
Seoul National
University College of Medicine, Korea
|
|
 |
Salmosin, A novel tumor angiogenesis inhibitor
Doo-Sik Kim
Yonsei Univ, Korea
|
|
|
|
|
